Why the study?
Does CARP overexpression prevent cardiac hypertrophy in response to pressure overload and neurohumoral stimulation in preclinical models?
Population
Cardiac-specific CARP-overexpressing transgenic mice and isolated neonatal Sprague-Dawley rat cardiomyocytes.
Comparison
Overexpression of CARP. vs Wild-type littermates and Ad-GFP infected or…
Design
Preclinical
Follow-up
4 weeks (TAC model) and 14 days (isoproterenol model)
Authors
Loading...
CARP may protect against pressure-overload hypertrophy; hypothesis-generating and leaves open clinical translation.
Does CARP overexpression prevent cardiac hypertrophy in response to pressure overload and neurohumoral stimulation in preclinical models?
CARP functions as an anti-hypertrophic factor in the heart by attenuating pressure overload- and agonist-induced hypertrophy through inhibition of the ERK1/2 and TGF-β signaling pathways.
Song et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: